Correction to: Cost-effectiveness analysis of umeclidinium bromide/vilanterol 62.5/25 mcg versus tiotropium/olodaterol 5/5 mcg in symptomatic patients with chronic obstructive pulmonary disease: a…

Overview of attention for article published in Respiratory Research, January 2019

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 15 Mendeley

So far, Altmetric has seen 1 X post from an account with 776 followers.

#respiratoryresearch Correction to: Cost-effectiveness analysis of umeclidinium bromide… https://t.co/yXqVwM6da8

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.